Evidence map›Paper›PMID 26201921›Full record

ArticleHepatology international2013

Downregulation of TIPE2 mRNA expression in peripheral blood mononuclear cells from patients with chronic hepatitis C.

Li Kong, Kun Liu, Yu-Zhuo Zhang, Meng Jin, Bo-Rong Wu, Wei-Zhen Wang, Wei Li, Yue-Min Nan, Youhai H Chen

Abstract read
PubMed Publisher
In one paragraph

Article in Hepatology international, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. TIPE Family of Proteins and Its Implications in Different Chronic Diseases.International journal of molecular sciences · 2018
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Expression and roles of TIPE2 in autoimmune hepatitis.Experimental and therapeutic medicine · 2017
    Article
  17. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Li KongDepartment of Hepatology, Third Hospital of Hebei Medical University, Shijiazhuang, 050051, China. kongliyouxiang@sina.com.
Kun LiuDepartment of Hepatology, Third Hospital of Hebei Medical University, Shijiazhuang, 050051, China.
Yu-Zhuo ZhangDepartment of Hepatology, Third Hospital of Hebei Medical University, Shijiazhuang, 050051, China.
Meng JinDepartment of Hepatology, Third Hospital of Hebei Medical University, Shijiazhuang, 050051, China.
Bo-Rong WuDepartment of Hepatology, Third Hospital of Hebei Medical University, Shijiazhuang, 050051, China.
Wei-Zhen WangDepartment of Hepatology, Third Hospital of Hebei Medical University, Shijiazhuang, 050051, China.
Wei LiDepartment of Experimental Center, Third Hospital of Hebei Medical University, Shijiazhuang, 050051, China.
Yue-Min NanDepartment of Hepatology, Third Hospital of Hebei Medical University, Shijiazhuang, 050051, China.
Youhai H ChenDepartment of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, 19104, USA.
Third Hospital of Hebei Medical University · CNHebei Medical University · CNHebei University of Chinese Medicine · CNUniversity of Pennsylvania · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeHepatitis C virus (HCV) infection causes chronic hepatitis in approximately 80 % of cases. Although it is well recognized that the immune system plays an important role in determining the outcomes of HCV infection, the underlying molecular mechanisms of persistent HCV infection and hepatic injury are incompletely understood. Tumor necrosis factor-α-induced protein 8-like 2 (TNFAIP8L2, TIPE2) is a newly identified negative regulator of innate and adaptive immunity. The goal of the present study is to investigate the potential role of TIPE2 in chronic hepatitis C (CHC) infection.

methodsWe used quantitative real-time reverse transcription polymerase chain reaction to examine the mRNA expression levels of TIPE2, Toll-like receptor (TLR) 2, and TLR4 in peripheral blood mononuclear cells from 60 CHC patients and 30 healthy controls.

resultsThe TIPE2 mRNA expression was significantly downregulated, whereas that of TLR2 and TLR4 was upregulated in CHC patients compared with healthy controls. TIPE2 mRNA expression levels were negatively correlated with serum ALT, AST, and HCV RNA levels. TIPE2 mRNA expression was also negatively correlated with TLR2 and TLR4 mRNA levels in CHC patients. Moreover, TIPE2 mRNA expression was upregulated, whereas that of TLR2 and TLR4 was downregulated after treatment of patients with interferon-α and ribavirin.

conclusionsThese results indicate that HCV may promote chronic hepatitis by decreasing TIPE2 expression while enhancing TLR signaling.

Indexed as

Chronic hepatitis CTLR2TLR4TNFAIP8L2

Identifiers

PMID26201921
OpenAlexW2082948037

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.